Ferula communis L. (Apiaceae) Root Acetone-Water Extract: Phytochemical Analysis, Cytotoxicity and In Vitro Evaluation of Estrogenic Properties

Ferula communis L. (F. communis) belongs to the Apiaceae family and is a herbaceous plant with various pharmaceutical properties, due to the different contents of bioactive compounds extracted mainly from its roots, as well as its leaves and rhizome. To date, this plant extract has demonstrated estrogenic, anti-inflammatory, antiproliferative, cytotoxic, antimicrobial and anti-neoplastic properties. Its estrogenic activity is justified by the presence of ferutinin, an ester of a sesquiterpenic alcohol that acts as an agonist for estrogen receptors, with a chemical formula equal to C22H3O4. The component present in F. communis responsible for the toxicity of the plant is ferulenol, a prenylated coumarin with the chemical formula C24H30O3. This compound is capable of inducing mortality via its strong anti-coagulant properties, leading to a lethal hemorrhagic syndrome, ferulosis, in animals that feed on a chemotype of F. communis containing a high amount of ferulenol. The removal of the component ferulenol makes extracts of Ferula non-toxic. In fact, the remaining prenylated coumarins are not present in concentrations sufficient to induce toxicity. The intake of high concentrations of the extract of this plant leads a double dose-dependent effect that is typical of sesquiterpenes such as ferutinin. Here, we assessed the cytotoxicity and the estrogenic properties of the F. communis phytocomplex obtained through extraction using a mixture of acetone and water. Among the active constituents of F. communis, the identification of ferutinin and ferulenol was performed using HPLC. The effects of the extract were evaluated, following the removal of ferulenol, on three cell lines: human breast cancer MCF-7, human cervical cancer HeLa and human osteoblastic sarcoma Saos-2. The choice of these cell lines was justified by the need to mimic certain processes which may occur in vivo and which are estrogen-dependent. The obtained results demonstrated that F. communis extract, in addition to possessing an estrogenic-like property, showed a dose-dependent effect. Low concentrations (0.1–0.8 μM) demonstrated a hyperproliferative effect, whereas higher concentrations (1.6–50 μM) were toxic. Therefore, this extract could be an excellent candidate to make up for a reduction or lack of estrogen.

[1]  Jaganmay Sarkar,et al.  Ferutinin induces osteoblast differentiation of DPSCs via induction of KLF2 and autophagy/mitophagy , 2022, Cell Death & Disease.

[2]  S. Qasim,et al.  Assessment of Ferula hermonis Boiss fertility effects in immature female rats supported by quantification of ferutinin via HPLC and molecular docking. , 2022, Journal of ethnopharmacology.

[3]  L. Quiñones,et al.  Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients , 2021, Frontiers in Pharmacology.

[4]  W. Wolfman,et al.  Guideline No. 422f: Menopause and Breast Cancer. , 2021, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[5]  F. Bosco,et al.  The Effect of Ferula communis Extract in Escherichia coli Lipopolysaccharide-Induced Neuroinflammation in Cultured Neurons and Oligodendrocytes , 2021, International journal of molecular sciences.

[6]  Rebecca D. Kehm,et al.  Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns , 2021, EClinicalMedicine.

[7]  S. Ross,et al.  Menopause experience in First Nations women and initiatives for menopause symptom awareness; a community-based participatory research approach , 2021, BMC Women's Health.

[8]  E. Karimi,et al.  Ferutinin: A phytoestrogen from ferula and its anticancer, antioxidant, and toxicity properties , 2021, Journal of biochemical and molecular toxicology.

[9]  Elahe Mahdipour,et al.  Osteogenic induction of menstrual blood mesenchymal stem cell by different Ferula species extracts , 2020, Avicenna journal of phytomedicine.

[10]  A. Fournier,et al.  Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study , 2020, Breast Cancer Research.

[11]  F. Bosco,et al.  Ferula L. Plant Extracts and Dose-Dependent Activity of Natural Sesquiterpene Ferutinin: From Antioxidant Potential to Cytotoxic Effects , 2020, Molecules.

[12]  V. McCormack,et al.  Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. , 2020, The Lancet. Global health.

[13]  Charalampos Proestos,et al.  Phenolic Acids of Plant Origin—A Review on Their Antioxidant Activity In Vitro (O/W Emulsion Systems) Along with Their in Vivo Health Biochemical Properties , 2020, Foods.

[14]  H. Stuppner,et al.  Antiausterity Activity of Secondary Metabolites from the Roots of Ferula hezarlalehzarica against the PANC-1 Human Pancreatic Cancer Cell Line , 2020, Journal of natural products.

[15]  R. Brinton,et al.  Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases , 2020, F1000Research.

[16]  M. El-Sabban,et al.  Ferula hermonis: a review of current use and pharmacological studies of its sesquiterpene ester ferutinin. , 2020, Current drug targets.

[17]  Muhammad Ali,et al.  Anticancer Plants: A Review of the Active Phytochemicals, Applications in Animal Models, and Regulatory Aspects , 2019, Biomolecules.

[18]  M. Phillips,et al.  Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action , 2019, Molecules.

[19]  R. Cumming,et al.  The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study , 2019, International journal of cancer.

[20]  D. Greenwood,et al.  Conference on ‘ Getting energy balance right ’ Postgraduate Diet, menopause and the risk of ovarian, endometrial and breast cancer , 2022 .

[21]  Saba Soltani,et al.  Histone deacetylase inhibitory and cytotoxic activities of the constituents from the roots of three species of Ferula , 2019, Iranian journal of basic medical sciences.

[22]  M. Joseph,et al.  Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signaling. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[23]  S. Muller,et al.  What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer? , 2018, ChemMedChem.

[24]  M. El-Sabban,et al.  A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  L. Vargas-Roig,et al.  Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells , 2018, PloS one.

[26]  M. Najaf Najafi,et al.  Cytotoxic activity of the genus Ferula (Apiaceae) and its bioactive constituents , 2018, Avicenna journal of phytomedicine.

[27]  N. Phillips,et al.  Genitourinary syndrome of menopause: Common problem, effective treatments , 2018, Cleveland Clinic Journal of Medicine.

[28]  B. Schneider,et al.  Sulfur-containing compounds from the roots of Ferula latisecta and their cytotoxic activities. , 2018, Fitoterapia.

[29]  Fang Xin,et al.  Recent Advances on Bioactive Constituents in Ferula , 2017, Drug development research.

[30]  F. Pérez-López,et al.  Deconstructing the genitourinary syndrome of menopause , 2017, International Urogynecology Journal.

[31]  M. Iranshahi,et al.  Phytochemistry and pharmacology of Ferula persica Boiss.: A review , 2017, Iranian journal of basic medical sciences.

[32]  F. Beretti,et al.  Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells. , 2016, Life sciences.

[33]  W. Mack,et al.  Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. , 2016, Atherosclerosis.

[34]  Mei-Ling Chen,et al.  [Chemotherapy-Induced Amenorrhea and Menopause Symptoms in Women With Breast Cancer]. , 2016, Hu li za zhi The journal of nursing.

[35]  M. Nicoletti,et al.  Chemical analysis of essential oils from different parts of Ferula communis L. growing in central Italy , 2016, Natural product research.

[36]  M. El-Sabban,et al.  Hemisynthesis, Antitumoral Effect, and Molecular Docking Studies of Ferutinin and Its Analogues , 2016, Chemical biology & drug design.

[37]  E. N. Kareva,et al.  [INFLUENCE OF PROGESTERONE DERIVATIVES ON THE VIABILITY AND EXPRESSION OF ESTROGEN RECEPTOR-ALPHA MRNA IN HELA CELLS.] , 2016, Eksperimental'naia i klinicheskaia farmakologiia.

[38]  A. Lenzi,et al.  Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model , 2016, Journal of Endocrinological Investigation.

[39]  M. Iranshahi,et al.  Review of the traditional uses, phytochemistry, pharmacology and toxicology of giant fennel (Ferula communis L. subsp. communis) , 2015, Iranian journal of basic medical sciences.

[40]  J. Behravan,et al.  Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins. , 2015, Fitoterapia.

[41]  B. Razavi,et al.  Antihypertensive effect of auraptene, a monoterpene coumarin from the genus Citrus, upon chronic administration , 2015, Iranian journal of basic medical sciences.

[42]  T. Sen,et al.  Medicinal plants, human health and biodiversity: a broad review. , 2014, Advances in biochemical engineering/biotechnology.

[43]  Z. Hochberg,et al.  Evidence of ERalpha and ERbeta selectivity and partial estrogen agonism in traditional Chinese medicine , 2014, Reproductive Biology and Endocrinology.

[44]  M. Iranshahi,et al.  Biological properties and molecular targets of umbelliprenin – a mini-review , 2014, Journal of Asian natural products research.

[45]  M. Matin,et al.  Investigating anticancer properties of the sesquiterpene ferutinin on colon carcinoma cells, in vitro and in vivo. , 2014, Life sciences.

[46]  M. Ferretti,et al.  Ferutinin dose-dependent effects on uterus and mammary gland in ovariectomized rats. , 2014, Histology and histopathology.

[47]  M. Iranshahi,et al.  Sesquiterpene lactones from Ferula oopoda and their cytotoxic properties , 2014, Journal of Asian natural products research.

[48]  M. Matin,et al.  Ferutinin, an apoptosis inducing terpenoid from Ferula ovina. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[49]  M. Iranshahi,et al.  Synthesis, biosynthesis and biological activities of galbanic acid – A review , 2014, Pharmaceutical biology.

[50]  T. Maraldi,et al.  Ferutinin promotes proliferation and osteoblastic differentiation in human amniotic fluid and dental pulp stem cells. , 2013, Life sciences.

[51]  M. Iranshahi A review of volatile sulfur-containing compounds from terrestrial plants: biosynthesis, distribution and analytical methods , 2012 .

[52]  S. Esmaeili,et al.  The Cytotoxic Effects of Ferula Persica var. Persica and Ferula Hezarlalehzarica against HepG2, A549, HT29, MCF7 and MDBK Cell Lines , 2012 .

[53]  M. Ferretti,et al.  Structural and histomorphometric evaluations of ferutinin effects on the uterus of ovariectomized rats during osteoporosis treatment. , 2012, Life sciences.

[54]  T. Efferth,et al.  Antibacterial Activity and Cytotoxicity of Selected Egyptian Medicinal Plants , 2011, Planta medica.

[55]  J. Behravan,et al.  Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. , 2011, Planta medica.

[56]  A. Capasso,et al.  Sesquiterpene coumarins from Ferula gumosa. , 2010, Journal of natural products.

[57]  M. Iranshahi,et al.  Evaluation of cytotoxicity and anticonvulsant activity of some Iranian medicinal Ferula species , 2010, Pharmaceutical biology.

[58]  A. Sahebkar,et al.  Badrakemonin, a New Eremophilane-Type Sesquiterpene from the Roots of Ferula badrakema Kos.-Pol. , 2009 .

[59]  B. Quesnel,et al.  Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines. , 2008, Phytochemistry.

[60]  Bernd Schneider,et al.  Polar secondary metabolites of Ferula persica roots. , 2008, Phytochemistry.

[61]  P. Christen,et al.  Analytical discrimination of poisonous and nonpoisonous chemotypes of giant fennel (Ferula communis L.) through their biologically active and volatile fractions. , 2006, Journal of agricultural and food chemistry.

[62]  M. Corasaniti,et al.  17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors. , 2005, Neurotoxicology.

[63]  R. Hopkins,et al.  Hormone Therapy in Postmenopausal Women , 2005 .

[64]  N. Maggiano,et al.  Antiproliferative effects of daucane esters from Ferula communis and F. arrigonii on human colon cancer cell lines , 2005, Phytotherapy research : PTR.

[65]  B. Fiebich,et al.  Calcium ionophoretic and apoptotic effects of ferutinin in the human Jurkat T-cell line. , 2004, Biochemical pharmacology.

[66]  N. Fuzzati,et al.  HPLC-DAD-MS identification of bioactive secondary metabolites from Ferula communis roots. , 2004, Fitoterapia.

[67]  A. Shafiee,et al.  A New Coumarin from Ferula persica , 2004 .

[68]  G. Cravotto,et al.  Daucane phytoestrogens: a structure-activity study. , 2002, Journal of natural products.

[69]  S. Kato,et al.  Terpenoids Found in the Umbelliferae Family Act as Agonists/Antagonists for ERα and ERβ: Differential Transcription Activity between Ferutinine-Liganded ERα and ERβ , 2002 .

[70]  S. Kato,et al.  Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and ERbeta: differential transcription activity between ferutinine-liganded ER(alpha) and ERbeta. , 2002, Biochemical and biophysical research communications.

[71]  G. Cravotto,et al.  Oxygenated sesquiterpenoids from a nonpoisonous sardinian chemotype of giant fennel (Ferula communis). , 2001, Journal of natural products.

[72]  D. Lamnaouer [Anticoagulant activity of coumarins from Ferula communis L]. , 1999, Therapie.